Export

EN
FR
Glecaprevir + pibrentasvir
Essential medicine status
General description

INN
Glecaprevir + pibrentasvir
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2019 (TRS 1021) for Chronic hepatitis C
Recommendations
Section
Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations
  • Oral > Solid: 50 mg + 20 mg granules
  • Oral > Solid > tablet: 100 mg + 40 mg